Company Filing History:
Years Active: 1999-2002
Title: Innovations of Elias Botvinick in Vascular Disease Treatment
Introduction
Elias Botvinick is a notable inventor based in San Rafael, CA (US). He has made significant contributions to the field of medicine, particularly in the treatment of occlusive peripheral vascular disease and coronary disease. With a total of 2 patents, his work focuses on innovative methods that promote angiogenesis and improve collateral coronary circulation.
Latest Patents
Botvinick's latest patents include a method for treating occlusive peripheral vascular disease and coronary disease. This invention discloses compositions and methods that allow for the treatment of diseases associated with the occlusion of coronary vessels. The methods involve the co-administration of an adenosine A receptor agonist, such as adenosine, and heparin or a heparin-like substance over several days. This approach is particularly applicable to improving collateral coronary circulation in patients suffering from myocardial infarction. Another significant patent relates to promoting angiogenesis using heparin and adenosine. This method also focuses on the co-administration of an adenosine receptor agonist and heparin over a period of several days to enhance the growth of new blood vessels.
Career Highlights
Elias Botvinick is affiliated with the University of California, where he continues to advance his research and innovations in vascular treatments. His work has garnered attention for its potential to significantly impact patient care in cardiology.
Collaborations
One of his notable collaborators is Hal V Barron, with whom he has worked on various projects related to his patents and research.
Conclusion
Elias Botvinick's contributions to the field of vascular disease treatment through his innovative patents highlight the importance of research in improving patient outcomes. His work continues to pave the way for advancements in medical treatments.